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Abstract 
Alzheimer’s disease (AD) is a chronic and slowly progressing neurodegenerative disorder which has become a major health 
concern worldwide. The literature has shown that oxidative stress is one of the most important risk factors behind the cause of 
AD. Oxidative stress often leads to the production of Reactive Oxygen Species (ROS).  
D-Galactose, a physiological nutrient and reducing sugar, non-enzymatically reacts with amines of amino acids in proteins and 
peptides to form Advanced Glycation End products which activate its receptors coupled to Biochemical pathways that stimulate 
free radical production and induces mitochondrial dysfunction which damages the neuron intracellularly. High dosage of D-
Galactose also suppresses the expression of nerve growth factors and its associated protein which results in the degeneration of 
nerve cells and reduction of acetylcholine levels in brain regions. 
This article put forwards the advantages of using Lactic Acid Bacteria (Probiotics) possessing anti-oxidant properties and which 
produces Acetyl Choline against D-Galactose induced Alzheimer’s disease. 
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Introduction 
Alzheimer’s disease (AD) is one of the most prevalent 
neurodegenerative disorder in the aged people across the 
world. Till date worldwide, nearly 44 million people have been 
affected by Alzheimer’s related dementia and it is estimated 
that more than 4 million and 5.3 million individuals have 
Alzheimer’s disease in India and the United States, 
respectively [1,2].  
 
It is projected that more than 13.5 million individuals will be 
having AD by the year 2050 [3]. AD is clinically characterized 
on the basis of the brain pathological hallmarks such as 
dystrophic neuritis, neurofibrillary tangles and β amyloid 
plaques derived from the amyloid precursor proteins [4]. 
 
Neurotoxicity of amyloid plaques not only increases oxidative 
stress which causes low-grade inflammation by activating the 
nuclear factor-kappa B (NF-κB) signalling pathway but also, 
accelerates the aging process which further leads to the 
generation of reactive oxygen species (ROS) [5-7]. ROS is 
involved in mitochondrial dysfunction and damage of 
neuronal membranes, proteins, lipids, and nucleic acids [8]. 
 
Prolonged supplementation of D-Galactose induces oxidative 
stress followed by mitochondrial dysfunction and intracellular 
damage of neurons, accelerating aging, and influencing age-
related cognitive decline in experimental animals [9]. 
 
D-Galactose Induced Alzheimer’s Disease 
D-Galactose induces aging-inducible oxidative stress in vivo, 
which resembles the natural aging process in mice [10, 11]. D-
Galactose is metabolized to galactose-1-phosphate at a 
normal concentration by D-galactokinase or galactose-1-
phosphate uridyl-transferase, but not at high levels. Instead, 
at increased concentration, D-galactose is converted to 
galactitol, which accumulates in cells and then induces 
osmotic stress and generates reactive oxygen species (ROS) 
which induces mitochondrial dysfunction and is the major 
cause of intracellular damage [12]. D-Galactose also reacts 
with the free amines of amino acids in peptides and proteins 
forming advanced glycation end-products (AGE) [13]. High 
dosage of D-Galactose also suppresses the expression of nerve 
growth factors and its associate protein resulting in the 
degeneration of nerve cells and reduction of acetylcholine 
levels in brain regions (Figure 1). 
 
 
Figure 1. D-Galactose induced Alzheimer’s Disease 
 
ROS activate inflammatory signaling molecules, such as the 
phosphatidylinositol 3-kinase (PI3K), nuclear factor-kappa B 
(NF-kB), Janus kinase (JAK) and mitogen-activated protein 
kinases (MAPK). It also induces the expression of tumor 
necrosis factor-alpha, interleukin-1b (IL-1b) and IL-6 [14]. D-
Galactose increases replicative senescence markers p16 
expression and telomere shortening but reduces doublecortin 
(DCX) expression [15]. Therefore, D-galactose continuously 
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stimulates low-grade inflammation, which is associated with 
the acceleration of aging. 
 
Lactic Acid Bacteria (Probiotics) and D-Galactose 
Induced Alzheimer’s Disease 
Lactic acid bacteria (LAB) are gram-positive, acid-tolerant and 
generally non-sporulating bacteria. The LAB is found in various 
food stuff like cheese, yogurt, and among the vagina and 
gastrointestinal microbiota. Most of LAB, Lactobacilli and 
Bifidobacteria, are microorganisms deemed beneficiall to us 
since they produce lactic acid as a major end product. 
Therefore, they are considered as safe products, due to their 
ubiquitous appearance in food and their contribution to the 
healthy microbiota [16].  
 
Lactobacillus is a gram-positive facultative anaerobic or 
microaerophilic rod-shaped bacteria. They also possesss 
various properties like anticancer, antioxidant, antidiabetic, 
antiobesity, and antihyperlipidemic effects [17].  
 
Recent studies have found that the L. plantarum versus 
pentosus showed a protective effect against memory deficit in 
AD-induced mice by D-Galactose and scopolamine [13,18]. 
Further, another study reported that L. Plantarum NDC75017 
improves the learning and memory ability in aging rats [19]. 
Previous reports proved that strong antioxidants increases the 
Na+, K+-ATPases activities by decreasing AChE (Acetyl 
cholinesterase) levels and improves the cognition by 
enhancing cholinergic transmission [20]. 
 
Lactobacillus plantarum MTCC1325 strain has the ability to 
produce Acetylcholine Neurotransmitter via both externally 
and internally pathway [21] and this strain also possess 
potential antioxidant activity. 
 
Chronic injection of D-Galactose induces memory impairment, 
neurodegeneration and oxidative damage in mice [22]. L. 
plantarum MTCC 1325 has the ability to produce the 
neurotransmitter viz. Acetylcholine [23] and also possesses 
potential antioxidant activity.  
 
Biochemically, it was well established that AD has been 
related to a significant decrease in the brain neurotransmitter 
ACh [24] and oxidative stress, eventually leading to imbalance 
production and detoxification of ROS, which is considered to 
be the important factor in the development of AD. AD-model 
rats showed a significant decline in total body weight, organ 
index, hair loss and skin elasticity[25].  Chronic administration 
of D-Galactose caused significant decline in spatial memory 
and reduced gross behaviorall activity which suggests 
impairment of memory [9]. 
 
From the comparative studies conducted for 60 days in rats, it 
was evident that chronic administration of L. plantarum 
MTCC1325 for 60 days showed significant improvement and 
recovery from AD. There was significant improvement in the  
activities of the membrane transport ATPases system in the 
selected brain regions of AD-induced group as well. Further, it 
was revealed that L. Plantarum MTCC1325 protects the 
neurons by stabilizing the structural and functional integrity of 
the biological membranes through the regulation of ionic 
concentration gradient by its antioxidant properties [26]. 
 
Similarly, the results on the cholinergic system indicated that 
chronic administration of D-Galactose caused a significant 
reduction in ACh level in brain due to dysfunction of 
cholinergic neurons and reduced activity of Choline 
acetyltransferase [27] while elevation in AChE activity was 
responsible for cognitive deficit, this condition was 
significantly ameliorated in both the regions of brain such as 
hippocampus and cerebral cortex by oral supplementation of 
L. plantarum MTCC1325.  
 
This may be associated with its potential antioxidant nature, 
Acetylcholine producing activities of L. plantarum MTCC1325 
and also bidirectional communication between the Gut-Bain 
Axis (Enteric Nervous System) [28]. The recent reviews on Gut-
Bain Axis communication describe the bacteria (micro biome) 
present in the gastro-intestinal tract may communicate with 
the brain and nervous system by different ways. 
 
Microbes have the ability to produce neurochemicals or 
neurotransmitters that are exact analoges in structure to 
those produced by the host nervous system and act as 
vehicles for neurotransmitters and influence the mood and 
behavior [29]. Microbes have also shown immunomodulatory 
effect by the release of host immune factors such as cytokines 
and inflammatory mediators that have known neuronal 
targets within both the CNS & ENS [30]. Most of the lactic acid 
bacteria and Probiotics may also activate the vagal nerves, 
which interacts with all neurons involved in the alleviation of 
behavioural changes like anxiety, learning and memory, 
Depression etc. [28]. It has been demonstrated that a 
probiotic bacterium (L. rhamnosus JB-1) influences the 
emotional behaviour in mice mediated via GABA receptor 
[31].  
 
Hence by above studies, it is observed that probiotics 
especially LAB could be useful in preventing/treating D-
Galactose Induced Alzheimer’s Disease. However, further 
research is required on higher mammalian experimental 
models such as rabbits, owl monkeys, vervet monkeys,  
squirrel monkeys,  and so on to  better  understand the 
possible role of Lactobacillus strains in the protection against 
neurodegenerative diseases. 
 
Conclusion 
Antioxidant and ACh producing L. plantarum MTCC 1325 has 
Anti-Alzheimer properties against D-Galactose induced 
Alzheimer’s disease since it resulted in body weight gain and 
organ index, improved the behavioral activity and learning 
skills through an elevation in the cholinergic neurotransmitter 
in the hippocampus and cerebral cortex regions of the brain 
and restored histopathological abnormalities back to the 
normal conditions.All these preliminary findings suggested 
that, the L. plantarum MTCC 1325 might have exerted 
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ameliorative effect against Alzheimer’s disease induced by D-
Galactose. 
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